Home
    • Plans Blog Contact
    Vicarious Surgical Inc. logo

    Vicarious Surgical Inc.

    RBOT
    Last price US$0.11
    Market cap US$1.0m
    12M price change N/A
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Abbott LaboratoriesABT Industry peer DexCom IncDXCM Industry peer Edwards Lifesciences CorpEW Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Vicarious Surgical Inc. Overview

    Industry: Medical Devices

    Sector: Healthcare

    Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headq Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Vicarious Surgical Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Mar 09, 2026

    Quarterly result summary

    Revenue was $0.4M (reported); EPS was $ (+2% YoY).

    Revenue $0.4M reported
    EPS $ +2% YoY
    Net loss -$0M reported

    What changed

    • Revenue reported to $0.4M; EPS +2% YoY to $.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing QUARTERLY REPORT Apr 30, 2026 SEC filing CURRENT REPORT Mar 09, 2026 SEC filing ANNUAL REPORT Mar 09, 2026 SEC filing QUARTERLY REPORT Nov 12, 2025 SEC filing CURRENT REPORT Nov 12, 2025 Earnings release PRESS RELEASE DATED NOVEMBER 12, 2025 Nov 12, 2025 Earnings release PRESS RELEASE DATED AUGUST 12, 2025 Aug 12, 2025 SEC filing CURRENT REPORT Aug 12, 2025 SEC filing QUARTERLY REPORT Aug 12, 2025 SEC filing CURRENT REPORT May 13, 2025 Earnings release PRESS RELEASE OF VICARIOUS SURGICAL INC. DATED MAY 12, 2025 May 13, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 1.00/5
    Vicarious Surgical Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Return on Equity

    Score -0.12/5
    Vicarious Surgical Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Vicarious Su... RBOT US$1.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.21/5
    Vicarious Surgical Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Vicarious Su... RBOT US$1.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Leverage

    Score 3.23/5
    Vicarious Surgical Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Vicarious Su... RBOT US$1.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Vicarious Surgical Inc. logo

    Vicarious Surgical Inc.

    US$0.11

    US$1.0m

    -44.42%

    N/A